Show Notes
Dementia caused by Alzheimer's is one of the most common symptoms for patients suffering from neurodegenerative diseases. That is why a lot of research has been directed towards understanding the actual impact of the disease on the brain. While there are several studies being conducted, the use of Biomarkers is among those that are in advanced stages. Biomarkers help in understanding as well as monitoring the disease progression in a patient over time.
Today, Lance Ladic, Siemens Healthineers’ Director of Strategic Innovation is joined by three guests - Tammie Benzinger, Professor of Radiology at the Mallinckrodt Institute in St. Louis at Washington University, Dr. Anne Börjesson-Hanson, Director of Clinical Trials at the Department for Aging at Kalinsky University Hospital, and Duygu Tosun-Turgut, Associate Professor at the University of California San Francisco in the Department of Radiology and Biomedical Imaging. They’ll help us understand the progress that has been made so far in the study of Alzheimer’s disease.
Stay tuned to learn about the options that are currently available in the detection of Alzheimer's disease. You’ll also learn about the use of Biomarkers in monitoring the disease’s progression and how that information can be used in managing it. Lastly, you’ll hear about the ongoing Alzheimer's research and the questions they are seeking answers for.
What You’ll Learn in This Episode: The process of detecting the Alzheimer's disease (01:43) Why it is important to detect the disease early (04:17) The role that biomarkers can play in managing the disease (12:35) How smartphone and wearable devices are helping in studying the disease (16:32) What the future of monitoring this disease will look like (19:20)
Connect with Duygu Tosun: LinkedIn Connect with Dr. Anne Börjesson-Hanson: LinkedIn Connect with Tammie Benzinger: LinkedIn Connect with Lance Ladic: LinkedIn Hosted on Acast. See acast.com/privacy for more information.
More from Healthcare Perspectives
In this episode of Healthcare Perspectives, host Isabel Nieto Alvarez, PhD, an expert for patient experience at Siemens Healthineers, is joined by Maria Bernathova, MD, breast radiologist and generative AI specialist, and Caroline Justich, breast cancer patient advocate and founder of the patient support initiative Be Accepted. Together, they discuss how better communication — and the responsible use of AI — could help patients feel more informed, involved, and supported throughout their care.
Across the globe, chronic kidney disease, diabetes, cardiovascular disease, and obesity continue to place a growing burden on healthcare systems. Many of these conditions develop silently, often remaining undetected until significant damage has already occurred.
Healthcare systems around the world are under increasing pressure to reduce their environmental footprint without compromising access to care, quality, or patient safety. One often overlooked opportunity is the refurbishment of imaging systems. By giving imaging systems a second life, healthcare providers can help preserve resources while continuing to deliver clinical performance.
Across the globe, radiology departments are grappling with a paradox: imaging volumes are climbing while the trained workforce needed to operate scanners is shrinking. Using AI-driven tools, a drive towards fully-automated radiology promises faster diagnoses, greater diagnostic accuracy, and more efficient workflows, improving both the patient and clinician experience. It is rapidly transforming the way medical imaging is performed, analyzed, and integrated into imaging workflows.
Medical imaging is already an integral part of modern healthcare, but as hospitals face growing imaging demand and staffing challenges, new solutions using artificial intelligence have become an effective way to help ease the load.